ABLi Therapeutics
ABLi Therapeutics is a startup headquartered in Atlanta, United States, founded in 2025. It has raised at least $1.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
ABLi Therapeutics has raised at least $1.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
ABLi Therapeutics sits inside the Atlanta R&D ecosystem in the Global R&D Labs Directory.
Other startups in Atlanta
- AlmataBio
- Amplifier
- Andson Biotech
- Dink Technologies
- Doculy
- Emrgy
- Falcomm
- Gridline Holdings
- HatchWorks Holdings
- Huxley Medical
- Kairos Water
Related
- Innovation profile of Atlanta
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does ABLi Therapeutics do?
ABLi Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has ABLi Therapeutics raised?
At least $1.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is ABLi Therapeutics based?
ABLi Therapeutics is headquartered in Atlanta, United States.
When was ABLi Therapeutics founded?
ABLi Therapeutics was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.